Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors
Clinical trial NCT00935545 · COMPLETED
Trial details
- NCT number
- NCT00935545
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.